1. A prospective observational safety study of patients with BRAFV600‐mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study). (1st May 2019) Authors: Corrie, P.G.; Terheyden, P.; ten Tije, A.J.; Herbst, R.; Jansen, R.; Marples, M.; Debus, D.; Marconcini, R.; Blasinska‐Morawiec, M.; Freivogel, K.; Munson, M.L.G.; Goodman, G.R.; Hsu, J.J.; Sadetsky, N.; Colburn, D.; Rutkowski, P. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study. (1st January 2014) Authors: Lorigan, P.; Marples, M.; Harries, M.; Wagstaff, J.; Dalgleish, A.G.; Osborne, R.; Maraveyas, A.; Nicholson, S.; Davidson, N.; Wang, Q.; Pericleous, L.; Bapat, U.; Middleton, M.R. Journal: British journal of dermatology Issue: Volume 170:Number 1(2014:Jan.) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A prospective observational safety study of patients with BRAFV600‐mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study). (10th February 2019) Authors: Corrie, P.G.; Terheyden, P.; ten Tije, A.J.; Herbst, R.; Jansen, R.; Marples, M.; Debus, D.; Marconcini, R.; Blasinska‐Morawiec, M.; Freivogel, K.; Munson, M.L.G.; Goodman, G.R.; Hsu, J.J.; Sadetsky, N.; Colburn, D.; Rutkowski, P. Journal: British journal of dermatology Issue: Volume 180:Number 5(2019) Page Start: 1254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Commentary: BRAF inhibitors for metastatic melanoma. (28th February 2013) Authors: Marples, M. Journal: British journal of dermatology Issue: Volume 168:Number 3(2013:Mar.) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study. (January 2014) Authors: Lorigan, P.; Marples, M.; Harries, M.; Wagstaff, J.; Dalgleish, A.G.; Osborne, R.; Maraveyas, A.; Nicholson, S.; Davidson, N.; Wang, Q.; Pericleous, L.; Bapat, U.; Middleton, M.R. Journal: British journal of dermatology Issue: Volume 170:Number 1(2014:Jan.) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗